VATIS UPDATE Article

The National Immunobiological Company (Nacimbio), part of Rostec state corporation, Russia, has signed an agreement on the transfer of technology for the production of ready-made dosage forms and active pharmaceutical substances with the pharmaceutical company , India, part of a global company Mylan NV, the United States.

Within the framework of the license agreement, there will be transfer of technology for the production of both ready-made forms and active pharmaceutical substances for the creation of modern combined drugs for the treatment of HIV infection. At the same time, the corporation is ready for a technological partnership in the pharmaceutical industry.

“We are developing our own drug production, jointly with well-known foreign pharmaceutical companies, who are ready to localize production of their products in Russia. “We are starting cooperation with Mylan NV. This will provide us with the supply of substances, transfer of technology and the creation of modern combination drugs for HIV treatment. As a result, their cost in the Russian market will significantly decrease,” said Sergei Chemezov, at Rostec.